Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca2+ accumulation in colonocytes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 293, Issue 5, 2007, Pages

  Kolar, Satya Sree N ^a   Barhoumi, Rola ^a,b   Callaway, Evelyn S ^a   Fan, Yang Yi ^a   Wang, Naisyin ^a   Lupton, Joanne R ^a,b   Chapkin, Robert S ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Chemoprevention; Fermentable fiber; Fish oil; n 3 polyunsaturated fatty acids

Indexed keywords

BUTYRIC ACID; CALCIUM; CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL STRAIN HCT116; CELL VIABILITY; COLON; COLON TUMOR; CONTROLLED STUDY; CRYPT CELL; CYTOSOL; HUMAN; HUMAN CELL; INTESTINE CELL; LIPID OXIDATION; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BUTYRATES; CALCIUM; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; COLON; COLONIC NEOPLASMS; DOCOSAHEXAENOIC ACIDS; HUMANS; INTESTINAL MUCOSA; LIPID PEROXIDATION; MALE; MITOCHONDRIA; RATS; RATS, SPRAGUE-DAWLEY; RUTHENIUM COMPOUNDS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 36148957839     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00312.2007     Document Type: Article

References (66)

1. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB, Reid ME, Ritenbaugh C, Vargas PA, Bhattacharyya AB, Earnest DL, Sampliner RE. Lack of effect of high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 342: 1156-1162, 2000.
2. An J, Chen Y, Huang ZJ. Critical upstream signals of cytochrome C release induced by a novel Bcl-2 inhibitor. J Biol Chem 279: 19133-19140, 2004.
3. Anti M, Armelao F, Marra G, Percesepe A, Bartoli GM, Palozza P, Parrella P, Canetta C, Gentiloni N, De Vitis I, Gasbarrini G. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 107: 1709-1718, 1994.
4. Archer SY, Meng S, Shei A, Hodin RA. p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95: 6791-6796, 1998.
5. 2 release in healthy subjects. Gastroenterology 105: 1317-1322, 1993.
6. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 160: 1115-1127, 2003.
7. Bayir H, Fadeel B, Palladino MJ, Witasp E, Kurnikov IV, Tyrurina YY, Tyurin VA, Amoscato AA, Jiang J, Kochanek PM, DeKosky ST, Greenberger JS, Shvedova AA, Kagan VE. Apoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondria. Biochim Biophys Acta 1757: 648-659, 2006.
8. Benard O, Balasubramanian KA. Modulation of glutathione level during butyrate-induced differentiation in human colon derived HT-29 cells. Mol Cell Biochem 170: 109-114, 1997.
9. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H, Tjonneland A, Overvad K, Martinez C, Dorronsoro M, Gonzalez CA, Key TJ, Trichopoulou A, Naska A, Vineis P, Tumino R, Krogh V, Bueno-de-Mesquita HB, Peeters PH, Berglund G, Hallmans G, Lund E, Skeie G, Kaaks R, Riboli E. Dietary fibre in food and protection against colorectal cancer in the European prospective investigation into cancer and nutrition (EPIC): an observational study. Lancet 361: 1496-1501, 2003.
10. 2+ waves in rat cortical astrocytes. J Cell Biol 145: 795-808, 1999.
11. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501, 1998.
12. Chang WC, Chapkin RS, Lupton JR. Fish oil blocks azoxymethane-induced tumorigenesis by increased cell Differentiation and apoptosis rather than decreased cell proliferation. J Nutr 18: 351-357, 1998.
13. Chang WCL, Chapkin RS, Lupton JR. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18: 721-730, 1997.
14. Chapkin RS, Hong MY, Fan YY, Davidson LA, Sanders LM, Henderson CE, Barhoumi R, Burghardt RC, Turner ND, Lupton JR. Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids 37: 193-199, 2002.
15. Chapkin RS, McMurray DN, Lupton JR. Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 23: 48-54, 2007.
16. Cheng J, Ogawa K, Kuriki K, Yokoyama Y, Kamiya T, Seno K, Okuyama H, Wang J, Luo C, Fujii T, Ickikawa H, Shirai T, Tokudome S. Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors. Cancer Lett 193: 17-24, 2003.
17. Chinopoulos C, Adam-Vizi V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J 272: 433-450, 2006.
18. Conquer JA, Holub BJ. Effect of supplementation with different doses of DHA on the levels of circulating DHA as nonesterified fatty acid in subjects of Asian Indian background. J Lipid Res 39: 286-292, 1998.
19. Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, Roda E, Kang JY, Leicester RJ. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 22: 765-776, 2007.
20. Davidson LA, Lupton JR, Jiang YH, Chapkin RS. Carcinogen and dietary lipid regulate ras expression and localization in rat colon without affecting farnesylation kinetics. Carcinogenesis 20: 785-791, 1999.
21. Davidson LA, Nguyen DV, Hokanson RM, Callaway ES, Isett RB, Turner ND, Dougherty ER, Wang N, Lupton JR, Carroll RJ, Chapkin RS. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 64: 6797-6804, 2004.
22. Fan YY, Zhang J, Barhoumi R, Burghardt RC, Turner ND, Lupton JR, Chapkin RS. Antagonism of CD95 signaling blocks butyrate induction of apoptosis in young adult mouse colonic cells. Am J Physiol Cell Physiol 277: C310-C319, 1999.
23. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nature Rev Cancer 5: 876-885, 2005.
24. Gardner HW. Oxygen radical chemistry of polyunsaturated fatty acids. Free Radic Biol Med 7: 65-86, 1989.
25. Giovannucci E, Willet W. Dietary factors and risk of colon cancer. Ann Med 26: 443-452, 1994.
26. Hajnoczky G, Hoek JB. Cell signaling. Mitochondrial longevity pathways. Science 315: 607-609, 2007.
27. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100: 57-70, 2007.
28. Hong MY, Chapkin RS, Barhoumi R, Burghardt RC, Turner ND, Henderson CE, Sanders LM, Fan YY, Davidson LA, Murphy ME, Spinka CM, Carroll J, Lupton JR. Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis 23: 1919-1925, 2002.
29. 6-methylguanine DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation. Cancer Epidemiol Biomarkers Prev 9: 819-826, 2000.
30. 2+ and sustained opening of the permeability transition pore. J Cell Sci 1115: 1175-1188, 2002.
31. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics. CA Cancer J Clin 54: 8-29, 2004.
32. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nature Chem Biol 1: 223-232, 2005.
33. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276: 4588-4596, 2001.
34. Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427: 360-364, 2004.
35. 2+ accumulation. Cancer Res 67: 5561-5568, 2007.
36. Kowaltowski AJ, Castilho RF, Vercesi AE. Mitochondrial permeability transition and oxidative stress. FEBS Lett 495: 12-15, 2001.
37. Lee DY, Lupton JR, Aukema HM, Chapkin RS. Dietary fat and fiber alter rat colonic mucosal lipid mediators and cell proliferation. J Nutr 123: 1808-1817, 1993.
38. Lupton JR. Microbial degradation products influence colon cancer risk; the butyrate controversy. J Nutr 134: 479-482, 2000.
39. Mariadason JM, Corner GA, Augenlicht LH. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 60: 4561-4572, 2000.
40. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694, 2001.
41. Ng Y, Barhoumi R, Tjalkens RB, Fan YY, Kolar S, Wang N, Lupton JR, Chapkin RS. The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis 26: 1914-1921, 2005.
42. 2+ stores. J Biol Chem 277: 20301-20308, 2002.
43. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, Muzeau F, Girodet J, Salmon RJ, Thomas G. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94: 12122-12127, 1997.
44. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442, 2003.
45. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett 149: 19-23, 2004.
46. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 85: 757-810, 2005.
47. Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, van den Brandt PA, Buring JE, Colditz GA, Freudenheim JL, Fuchs CS, Giovannucci E, Goldbohm RA, Graham S, Harnack L, Hartma M, Jacob DR Jr, Kato I, Krogh V, Leitzmann MF, McCullough ML, Miller AB, Pietinen P, Rohan TE, Schatzkin A, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Smith-Warner SA. Dietary fiber intake and risk of colorectal cancer. A pooled analysis of prospective cohort studies. JAMA 294: 2849-2857, 2005.
48. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361: 1491-1495, 2003.
49. Pinhero JC, Bates DM. Mixed Effects Models in S and S-PLUS. New York: Springer Verlag, 2000.
50. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2006.
51. Rahman-Roblick R, Roblick UJ, Hellman U, Conrotto P, Liu T, Becker S, Hirschberg D, Jornvall H, Auer G, Wiman KG. p53 targets identified by protein expression profiling. Proc Natl Acad Sci USA 104: 5401-5406, 2007.
52. +: molecular determinants and functional consequences. Physiol Rev 86: 369-408, 2006.
53. Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, Wang N, Spinka CM, Carroll RJ, Turner ND, Chapkin RS, Lupton JR. Enhancement of reactive oxygen species by dietary fish oil and attenuation of antioxidant defenses by dietary pectin coordinately heightens apoptosis in rat. J Nutr 134: 3233-3238, 2004.
54. Sarkar FH, Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66: 3347-50, 2006.
55. Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signalling. J Biol Chem 276: 12035-12040, 2001.
56. Shibue T, Suzuki S, Okamoto H, Yoshida H, Ohba Y, Takaoka A, Taniguchi T. Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways. EMBO J 25: 4952-4962, 2006.
57. Siniscrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237-241, 1995.
58. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR. Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 99: 9433-9438, 2002.
59. Smith JG, Yokoyama WH, German JB. Butyric acid from the diet: actions at the level of gene expression. Crit Rev Food Sci 38: 259-297, 1998.
60. Spector AA. Essentiality of fatty acids. Lipids 34: S1-S3, 1999.
61. Starkov AA, Chinopoulos C, Fiskum G. Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 36: 257-264, 2004.
62. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604, 2001.
63. Whelan J, McEntee MF. Dietary (n-6) PUFA and intestinal tumorigenesis. J Nutr 134: 3421S-3426S, 2004.
64. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673-682, 2001.
65. Zhang J, Wu G, Chapkin RS, Lupton JR. Energy metabolism of rat colonocytes changes during the tumorigenic process and is dependent on diet and carcinogen. J Nutr 128: 1262-1269, 1998.
66. Zhang P, Smith R, Chapkin RS, McMurray DN. Dietary (n-3) polyunsaturated fatty acids modulate murine Th1/Th2 balance toward the Th2 pole by suppression of Th1 development. J Nutr 135: 1745-1751, 2005.